Viewing nowActoPeace Tablets (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Eden Pharma Co., Ltd.

MFDS item code 201404064 · Approved 2014.09.01 · Insurance code 628900130
Improves glycemic control in type 2 diabetes mellitus
This medication is an adjunct used in conjunction with diet and exercise to improve blood sugar control in patients with type 2 diabetes. It can be administered alone, but if blood sugar improvement has not been achieved despite using other oral hypoglycemic agents, it should be used in combination with sulfonylureas, metformin, or insulin. In addition to drug therapy, patients with type 2 diabetes should also undergo nutritional counseling, weight control, and exercise therapy, and these efforts are crucial not only for initial treatment but also for maintaining long-term treatment effects. Therefore, this medication is used to improve patients' blood sugar control.
Administer this medicine orally once daily, regardless of meals. In patients with diabetes, administer for an appropriate period to assess changes in glycated hemoglobin (at least 3 months), provided that glycemic control does not worsen further. 1. Monotherapy: Treatment may be initiated with pioglitazone 15 mg once daily. If the initial dose is not sufficiently effective, the dose may be increased to 30 mg once daily. 2. Combination therapy 1) Sulfonylurea: The initial dose is 15 mg once daily. The current sulfonylurea may be continued at the same dose and schedule. If the patient develops symptoms of hypoglycemia, the sulfonylurea dose should be reduced. 2) Metformin: The initial dose is 15 mg once daily. The current metformin may be continued at the same dose and schedule. 3) Insulin: The dose is 15 mg once daily. The current insulin dose may be maintained when initiating combination therapy. If the patient develops symptoms of hypoglycemia or the plasma glucose concentration decreases to 100 mg/dL or less, the insulin dose may be reduced by 10 ~ 25 %. Subsequent dose adjustments should be individualized according to glycemic control. Maximum recommended dose: For monotherapy or combination therapy with a sulfonylurea, metformin, or insulin, doses exceeding 30 mg once daily are not recommended.
Use is not recommended in children under 18 years of age because there is no experience with its use in this population.
This medication is used to treat type 2 diabetes by assisting insulin action to control blood sugar levels. It may put a burden on the heart, so it should not be used by patients with heart failure or a history of heart failure. During treatment, symptoms of heart failure, such as weight gain, edema, and shortness of breath, should be monitored closely, and if symptoms occur, immediate consultation with a physician is necessary. This medication may cause fluid retention, so it should be taken with caution by patients with cardiovascular diseases or edema. It should not be administered to patients with active bladder cancer or a history of bladder cancer, and if hematuria or urinary disturbances occur during treatment, it is essential to inform medical personnel immediately. Patients with impaired liver function should also take this medication with caution and undergo regular liver function tests during treatment. The risk of hypoglycemia may increase when used in combination with other hypoglycemic agents or insulin, so patients should be well aware of the symptoms of hypoglycemia. Premenopausal women may experience ovulation stimulation while taking this medication, so appropriate contraceptive methods should be used if pregnancy is not desired. Elderly patients and those with impaired renal function should also take this medication with caution and adjust the dosage according to the physician's instructions. This medication is taken once daily regardless of meals, and if a dose is missed, care should be taken to avoid double dosing the next day. It is important to consult medical personnel immediately if abnormal symptoms or discomfort occur during use.
Congestive heart failure, excessive and rapid weight changes, shortness of breath, edema, fluid retention, inadequate blood sugar control, upper respiratory infection, headache, sinusitis, myalgia, pharyngitis, abdominal distension, weight gain, hypoglycemia, urinary tract infection, low back pain, dizziness, elevated serum creatine kinase, hypertension, heart failure, limb pain, chest pain, death due to cardiovascular predisposition, worsening of congestive heart failure, emergency room visit due to congestive heart failure, progression of congestive heart failure, liver failure, diabetic macular edema accompanied by vision loss, elevated serum ALT levels, elevated serum bilirubin levels, decreased hemoglobin, decreased hematocrit, increased serum creatinine, dizziness, loss of appetite, constipation, upper abdominal pain, chest pain, fatigue, weakness, indigestion, nausea, shortness of breath, itching, chest discomfort, tremors, chills, gastrointestinal disease, abdominal pain, epigastric discomfort, numbness, muscle rigidity, head discomfort, increased liver enzymes, worsening of liver disease, hives, eczema, joint pain, knee abnormalities, arm weakness syndrome, proteinuria, anxiety, insomnia, drowsiness, simple herpes, blurred vision, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, abdominal pain, heart failure, fracture
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that is protected from light and air, avoiding places with high humidity. It is important to maintain an appropriate storage temperature between 15 degrees and 30 degrees.
White to grayish round tablets
30 tablets/bottle, 90 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Eden Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.